Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04105907 · ClinicalTrials.gov registry record · NA
Histological Evaluation in the Efficacy of GentleWave in Root Canal Pulp Tissue Debridement and Disinfection of Difficult to Reach Areas in Mandibular Human Molars II. An In-vivo Study.
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04105907 is a NA study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 50 participants.
The verdict
NCT04105907, a NA study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to understand and learn better the efficacy of GentleWave and obtain histological evidence of the efficacy of this new technology done in-vivo
Interventions
- DEVICE GentleWave
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04105907
The ClinicalTrials.gov registry entry for NCT04105907 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GentleWave is the first listed.
NCT04105907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04105907 about?
NCT04105907 is a clinical study titled "Histological Evaluation in the Efficacy of GentleWave in Root Canal Pulp Tissue Debridement and Disinfection of Difficult to Reach Areas in Mandibular Human Molars II. An In-vivo Study.". The purpose of this study is to understand and learn better the efficacy of GentleWave and obtain histological evidence of the efficacy of this new technology done in-vivo
What is the current status of trial NCT04105907?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-11-01. Estimated completion is 2026-11-01.
What interventions are being tested in trial NCT04105907?
The interventions under investigation include: GentleWave (DEVICE).
Who is sponsoring clinical trial NCT04105907?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.